FDA Taps Pazdur To Head Oncology Center, Seeks To Establish ‘Navigator’ Program For Expanded Access

June 29, 2016 at 9:34 AM
FDA tapped the director of the Office of Hematology and Oncology Products, Richard Pazdur, to head the agency’s new Oncology Center of Excellence that will focus on uniting cancer product regulatory review and leverage clinical expertise across FDA as part of the vice president’s Cancer Moonshot Initiative. As part of this scheme, the agency is also scaling up efforts to provide accessible and time-saving information to physicians and patients pursuing expanded access requests for investigational drugs. The agency’s plans were...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.